申请人:eXIthera Pharmaceuticals Inc.
公开号:US20150225389A1
公开(公告)日:2015-08-13
The present invention provides compounds and compositions that inhibit Factor XIa or kallikrein and methods of using these compounds and composition.
本发明提供了抑制XIa因子或激肽酶的化合物和组合物,以及使用这些化合物和组合物的方法。